Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Plos Genetics|January 10, 2013
Adult onset global loss of the fto gene alters body composition and metabolism in the mouseFiona McMurray, Chris D Church, Rachel Larder, et al.
Nature Communications|September 10, 2021
Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapyJoan Bertolin, Víctor Sánchez, Albert Ribera, et al.
The Journal of Clinical Investigation|July 19, 2013
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapyVirginia Haurigot, Sara Marcó, Albert Ribera, et al.
Molecular Therapy. Methods & Clinical Development|November 11, 2021
Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animalSara Marcó, Virginia Haurigot, Maria Luisa Jaén, et al.
Diabetes|February 5, 2013
Treatment of diabetes and long-term survival after insulin and glucokinase gene therapyDavid Callejas, Christopher J Mann, Eduard Ayuso, et al.
Cell|October 7, 2023
Arginine reprograms metabolism in liver cancer via RBM39Dirk Mossmann, Christoph Müller, Sujin Park, et al.
Endocrinology|February 27, 2018
Deletion of the RabGAP TBC1D1 Leads to Enhanced Insulin Secretion and Fatty Acid Oxidation in Islets From Male MiceTorben Stermann, Franziska Menzel, Carmen Weidlich, et al.
Molecular Metabolism|February 12, 2024
Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapySergio Muñoz, Joan Bertolin, Veronica Jimenez, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2012
Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetesFrancisco J Ortega, Josep M Mercader, José M Moreno-Navarrete, et al.
Pageof 9